PFIZER INC — Director's Dealing 2020

Feb 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-02-26

Reporting Person: MACKENZIE ALEXANDER R (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-26	Common Stock	A	21202.0000	$0.0000	Acquired	101323.0000	Direct
2020-02-26	Common Stock	A	17087.0000	$0.0000	Acquired	118410.0000	Direct
2020-02-26	Common Stock	F	7984.0000	$34.7200	Disposed	110426.0000	Direct
2020-02-26	Common Stock	F	8104.0000	$34.7200	Disposed	102322.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-27	Stock Appreciation Rights	$34.1000	A	102221.0000	Acquired	2025-02-27	Common Stock (102221.0000)	Direct
2020-02-27	Stock Appreciation Rights	$34.1000	A	87581.0000	Acquired	2027-02-27	Common Stock (87581.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9702.0000	Indirect

Footnotes

F1: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).

F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).

F3: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F4: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.